144
Views
7
CrossRef citations to date
0
Altmetric
Urology

Association of interleukin-18 gene polymorphisms with calcium oxalate kidney stone disease

, , , , , , , , , , , , , , , & show all
Pages 20-26 | Received 26 Jun 2009, Accepted 28 Oct 2009, Published online: 18 Dec 2009

References

  • Lewandowski S, Rodgers AL. Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment. Clin Chim Acta 2004;345:17–34.
  • Abdel-Halim RE. Urolithiasis in adults. Clinical and biochemical aspects. Saudi Med J 2005;26:705–13.
  • Amato M, Lusini ML, Nelli F. Epidemiology of nephrolithiasis today. Urol Int 2004;72(Suppl 1):1–5.
  • Goldfarb DS, Fischer ME, Keich Y, Goldberg J. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 2005;67:1053–61.
  • Edvardsson VO, Palsson R, Indridason OS, Thorvaldsson S, Stefansson K. Familiality of kidney stone disease in Iceland. Scand J Urol Nephrol 2009;43:1–5.
  • Tsai FJ, Wu HC, Chen HY, Lu HF, Hsu CD, Chen WC. Association of E-cadherin gene 3´-UTR C/T polymorphism with calcium oxalate stone disease. Urol Int 2003;70:278–81.
  • Loder N. Genetic variations can point the way to disease genes. Nature 1999;401:734.
  • Chen WC, Chen HY, Lu HF, Hsu CD, Tsai FJ. Association of the vitamin D receptor gene start codon Fok I polymorphism with calcium oxalate stone disease. BJU Int 2001;87:168–71.
  • Bid HK, Kumar A, Kapoor R, Mittal RD. Association of vitamin D receptor-gene (FokI) polymorphism with calcium oxalate nephrolithiasis. J Endourol 2005;19:111–5.
  • Jackman SV, Kibel AS, Ovuworie CA, Moore RG, Kavoussi LR, Jarrett TW. Familial calcium stone disease: TaqI polymorphism and the vitamin D receptor. J Endourol 1999;13:313–6.
  • Chen WC, Wu HC, Lin WC, Wu MC, Hsu CD, Tsai FJ. The association of androgen- and oestrogen-receptor gene polymorphisms with urolithiasis in men. BJU Int 2001;88:432–6.
  • Chen WC, Wu HC, Lu HF, Chen HY, Tsai FJ. Calcitonin receptor gene polymorphism: a possible genetic marker for patients with calcium oxalate stones. Eur Urol 2001;39:716–9.
  • Mittal RD, Bid HK, Manchanda PK, Kapoor R. Association of interleukin-1beta gene and receptor antagonist polymorphisms with calcium oxalate urolithiasis. J Endourol 2007;21:1565–70.
  • Chen WC, Wu HC, Chen HY, Wu MC, Hsu CD, Tsai FJ. Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones. Urol Res 2001;29:321–4.
  • Ozturk M, Kordan Y, Cangul H, Dogan HS, Kilicarslan H, Vuruskan H, Association of urokinase gene 3´-UTR T/C polymorphism with calcium oxalate urolithiasis in children. Int Urol Nephrol 2008;40:563–8.
  • Tsai FJ, Lin CC, Lu HF, Chen HY, Chen WC. Urokinase gene 3´-UTR T/C polymorphism is associated with urolithiasis. Urology 2002;59:458–61.
  • Chen WC, Chen HY, Wu HC, Wu MC, Hsu CD, Tsai FJ. Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease. Urol Res 2003;31:218–22.
  • Onaran M, Yilmaz A, Sen I, Ergun MA, Camtosun A, Kupeli B, Heparan sulfate gene polymorphism in calcium oxalate nephrolithiasis. Urol Res 2009;37:47–50.
  • Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, Gudbjartsson DF, Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 2009;41:926–30.
  • Khan SR, Kok DJ. Modulators of urinary stone formation. Front Biosci 2004;9:1450–82.
  • Khan SR. Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol 2004;98:e55–60.
  • Jonassen JA, Kohjimoto Y, Scheid CR, Schmidt M. Oxalate toxicity in renal cells. Urol Res 2005;33:329–39.
  • Schepers MS, van Ballegooijen ES, Bangma CH, Verkoelen CF. Oxalate is toxic to renal tubular cells only at supraphysiologic concentrations. Kidney Int 2005;68:1660–9.
  • Rhee E, Santiago L, Park E, Lad P, Bellman GC. Urinary IL-6 is elevated in patients with urolithiasis. J Urol 1998;160:2284–8.
  • Thompson SR, Humphries SE. Interleukin-18 genetics and inflammatory disease susceptibility. Genes Immun 2007;8:91–9.
  • Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007;27:98–114.
  • Dong GP, Yu ZS, Liang L, Zou CC, Fu JF, Wang CL. IL-18 gene promoter –137C/G and –607C/A polymorphisms in Chinese Han children with type 1 diabetes mellitus. Int J Immunogenet 2007;34:75–9.
  • Kretowski A, Mironczuk K, Karpinska A, Bojaryn U, Kinalski M, Puchalski Z, Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002;51:3347–9.
  • Lee CC, Lin WY, Wan L, Tsai Y, Lin YJ, Tsai CH, Interleukin-18 gene polymorphism, but not interleukin-2 gene polymorphism, is associated with rheumatoid arthritis. Immunogenetics 2007;59:433–9.
  • Arimitsu J, Hirano T, Higa S, Kawai M, Naka T, Ogata A, IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem Biophys Res Commun 2006;342:1413–6.
  • Heilberg IP, Teixeira SH, Martini LA, Boim MA. Vitamin D receptor gene polymorphism and bone mineral density in hypercalciuric calcium-stone-forming patients. Nephron 2002;90:51–7.
  • Nishijima S, Sugaya K, Naito A, Morozumi M, Hatano T, Ogawa Y. Association of vitamin D receptor gene polymorphism with urolithiasis. J Urol 2002;167:2188–91.
  • Vezzoli G, Soldati L, Proverbio MC, Adamo D, Rubinacci A, Bianchi G, Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones. J Nephrol 2002;15:158–64.
  • Mossetti G, Vuotto P, Rendina D, Numis FG, Viceconti R, Giordano F, Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis. J Intern Med 2003;253:194–200.
  • Ozkaya O, Soylemezoglu O, Misirlioglu M, Gonen S, Buyan N, Hasanoglu E. Polymorphisms in the vitamin D receptor gene and the risk of calcium nephrolithiasis in children. Eur Urol 2003;44:150–4.
  • Rendina D, Mossetti G, Viceconti R, Sorrentino M, Castaldo R, Manno G, Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients. Urology 2004;64:833–8.
  • Bid HK, Chaudhary H, Mittal RD. Association of vitamin-D and calcitonin receptor gene polymorphism in paediatric nephrolithiasis. Pediatr Nephrol 2005;20:773–6.
  • Mittal RD, Bid HK, Kumar A, Bhandari M. Association of urokinase gene 3´-UTR polymorphism with calcium oxalate nephrolithiasis. J Endourol 2006;20:157–60.
  • Mittal RD, Bid HK, Manchanda PK. Genotype and haplotype determination of IL1B (g. –511C>T and g. +3954C>T) and (IL1RN) in pediatric nephrolithiasis. Clin Chim Acta 2007;379:42–7.
  • Striz I, Krasna E, Honsova E, Lacha J, Petrickova K, Jaresova M, Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft. Immunol Lett 2005;99:30–5.
  • Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol 2007;156:203–12.
  • Gauer S, Sichler O, Obermuller N, Holzmann Y, Kiss E, Sobkowiak E, IL-18 is expressed in the intercalated cell of human kidney. Kidney Int 2007;72:1081–7.
  • Sale MM, Mychaleckyj JC, Chen WM. Planning and Executing a Genome Wide Association Study (GWAS). Methods Mol Biol 2009;590:403–18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.